Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates ... s screening and hit to lead capabilities, is powerful ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Regional Analysis: North America holds 40% of the Generative AI Life Sciences market... Lawrence John Prudour +91 91308 55334 ...

Next, they need experiential evidence that will support progressing these revealed prioritised targets into the discovery of lead molecules ... on the AI-created drug molecule DSP-1181 for ...

Now, Scripps Research scientists have uncovered new structures of transthyretin. Their findings, published in Nature Structural & Molecular Biology on January 22, 2025, show how the three-dimension ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle ...

This discovery could also contribute ... and misfolding could occur then lead to the clumping of the protein and subsequent disease. Attaching the ATTR drug tafamidis-developed b+y the Kelly ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.